These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22051845)

  • 1. A review on adherence management in patients on oral cancer therapies.
    Wood L
    Eur J Oncol Nurs; 2012 Sep; 16(4):432-8. PubMed ID: 22051845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to oral cancer therapies: nursing interventions.
    Winkeljohn D
    Clin J Oncol Nurs; 2010 Aug; 14(4):461-6. PubMed ID: 20682501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient adherence and persistence with oral anticancer treatment.
    Ruddy K; Mayer E; Partridge A
    CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonadherence in patients with breast cancer receiving oral therapies.
    Moore S
    Clin J Oncol Nurs; 2010 Feb; 14(1):41-7. PubMed ID: 20118025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents.
    Decker V; Spoelstra S; Miezo E; Bremer R; You M; Given C; Given B
    Cancer Nurs; 2009; 32(6):E20-9. PubMed ID: 19816160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
    Gebbia V; Bellavia G; Ferraù F; Valerio MR
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S49-59. PubMed ID: 22149481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.
    Bedell CH
    Clin J Oncol Nurs; 2003; 7(6 Suppl):5-9. PubMed ID: 14705494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
    Gater A; Heron L; Abetz-Webb L; Coombs J; Simmons J; Guilhot F; Rea D
    Leuk Res; 2012 Jul; 36(7):817-25. PubMed ID: 22364811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient adherence with oral oncolytic therapies.
    Vioral A; Leslie M; Best R; Somerville D
    Semin Oncol Nurs; 2014 Aug; 30(3):190-9. PubMed ID: 25085031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.
    Haverkamp F; Johansson L; Dumas H; Langham S; Tauber M; Veimo D; Chiarelli F
    Clin Ther; 2008 Feb; 30(2):307-16. PubMed ID: 18343269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of oral medications in patients with advanced breast cancer.
    Palmieri FM; Barton DL
    Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S17-22. PubMed ID: 18054678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
    Doggrell SA
    Breast Cancer Res Treat; 2011 Sep; 129(2):299-308. PubMed ID: 21594663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the challenges related to oral agents for cancer and their impact on adherence.
    Tipton JM
    Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):37-40. PubMed ID: 26030391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
    Foulon V; Schöffski P; Wolter P
    Acta Clin Belg; 2011; 66(2):85-96. PubMed ID: 21630604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists.
    Timmers L; Boons CC; Verbrugghe M; van den Bemt BJ; Van Hecke A; Hugtenburg JG
    BMC Cancer; 2017 Feb; 17(1):122. PubMed ID: 28187759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of depressive disorders on adherence to oral anti-cancer treatment].
    Chabrier M; Bezy O; Mouret MA; Bay JO; Jalenques I
    Bull Cancer; 2013 Oct; 100(10):1017-22. PubMed ID: 24067889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of antineoplastic agents: the challenges for healthcare professionals.
    Tadic D; Spasojevic IB; Tomasevic ZI; Dejanovic SD
    J BUON; 2015; 20(3):690-8. PubMed ID: 26214619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.
    Liewer S; Huddleston AN
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):453-64. PubMed ID: 25683755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of medication adherence in children and adults with ADHD.
    Adler LD; Nierenberg AA
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in oral cancer drugs raises thorny issues for oncology practices.
    Hede K
    J Natl Cancer Inst; 2009 Nov; 101(22):1534-6. PubMed ID: 19880814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.